Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation

被引:8
|
作者
Fukazawa, Kyota [1 ]
Nishida, Seigo [2 ,3 ]
Pretto, Ernesto A., Jr. [4 ]
Vater, Youri [1 ]
Reyes, Jorge D. [5 ]
机构
[1] Univ Washington, Div Transplantat, Dept Anesthesiol & Pain Med, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA
[2] Univ Miami, Miller Sch Med, Div Liver & Gastrointestinal Transplant, Dept Surg, Miami, FL 33136 USA
[3] Jackson Mem Hosp, Miami, FL 33136 USA
[4] Univ Miami, Miller Sch Med, Div Solid Organ Transplantat, Dept Anesthesiol Perioperat Med & Pain Management, Miami, FL 33136 USA
[5] Univ Washington, Sch Med, Dept Surg, Div Transplantat, Seattle, WA 98195 USA
关键词
Body surface area; Liver transplant; Model for end-stage liver disease; Size mismatch; Survival; PORTAL VENOUS-PRESSURE; CLINICAL-IMPLICATIONS; BACTERIAL TRANSLOCATION; PORTACAVAL-SHUNT; WATER-RETENTION; VEIN PRESSURE; HEPATITIS-C; MELD SCORE; CIRRHOSIS; HYPERPERFUSION;
D O I
10.1002/jhbp.355
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundIn orthotopic liver transplantation (OLT) size-mismatch may cause adverse outcomes. We previously reported on a method to predict donor-recipient size-mismatch using the body surface area index (BSAi). In this study, we hypothesized that graft survival of size-mismatch transplantation deteriorates with higher model for end-stage liver disease (MELD) score at transplantation. MethodsWe evaluated non-parametrically the association of BSAi and MELD with 1-year graft survival with a generalized additive model. For derivation, transplantations performed between 2005 and 2010 were used. The associations were then validated by comparing Kaplan-Meier estimates between patient groups stratified according to estimated risk, using transplantations from 2011-2013. ResultsA total of 30,870 OLT were included in the study with 16,466 in the validation group. The derivation model revealed that graft survival significantly decreased with higher or lower BSAi, and with higher MELD (P < 0.0001). Validation confirmed the correlation of observed graft survival with estimated risk categories. ConclusionsWe found that there is an interactive effect between MELD score and size-mismatch. Also high MELD recipient has a narrower safety margin for size-mismatched graft. The risk calculated from our nonparametric model with MELD and BSAi well predicts outcome in liver transplantation.
引用
收藏
页码:406 / 413
页数:8
相关论文
共 50 条
  • [1] Detrimental Effect of Size-Mismatched Liver Transplantation On Graft Survival for Nonalcoholic Steatohepatitis Kyota
    Fukazawa, Kyota
    Vitin, Alexander
    Vater, Yuri
    Martay, Kenneth
    Tzevan, Poon
    Reyes, Jorge
    TRANSPLANTATION, 2015, 99 : 232 - 232
  • [2] Liver Transplantation in Recipients With High Model for End-stage Liver Disease Score
    Gonzalez Martinez, S.
    Molina Raya, A.
    Becerra Massare, A.
    Muffak Granero, K.
    Villegas Herrera, T.
    Villar del Moral, J. M.
    Fundora Suarez, Y.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (02) : 595 - 597
  • [3] Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35
    Yun, Sang Oh.
    Kim, Jongman
    Rhu, Jinsoo
    Choi, Gyu-Seong
    Joh, Jae-Won
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (12) : 1293 - 1303
  • [4] Improved Outcome of Adult Recipients with a High Model for End-Stage Liver Disease Score and a Small-For-Size Graft
    Yi, Nam-Joon
    Suh, Kyung-Suk
    Lee, Hae Won
    Shin, Woo Young
    Kim, Juhyun
    Kim, Won
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    Lee, Kuhn Uk
    LIVER TRANSPLANTATION, 2009, 15 (05) : 496 - 503
  • [5] Use of Model for End-Stage Liver Disease Exceptions for Donation After Cardiac Death Graft Recipients Relisted for Liver Transplantation
    Maduka, Richard C.
    Abt, Peter L.
    Goldberg, David S.
    LIVER TRANSPLANTATION, 2015, 21 (04) : 554 - 560
  • [6] Model for end-stage liver disease score does not predict patient or graft survival in living donor liver transplant recipients
    Hayashi, PH
    Forman, L
    Steinberg, T
    Bak, T
    Wachs, M
    Kugelmas, M
    Everson, GT
    Kam, I
    Trotter, AF
    LIVER TRANSPLANTATION, 2003, 9 (07) : 737 - 740
  • [7] Does the model for end-stage liver disease (MELD) predict post liver transplant graft survival?
    Wiesner, RH
    Edwards, E
    Freeman, R
    Harper, A
    HEPATOLOGY, 2003, 38 (04) : 370A - 371A
  • [8] Mind the Model for End-Stage Liver Disease: Model for End-Stage Liver Disease Score as an Indicator of Hemoderivate Transfusion and Survival in Liver Transplantation
    Alonso, I. J.
    Maestro, O. C.
    Gomez, N. F.
    Mateos, R. S.
    Quinto, A. M.
    Molero, F. C.
    Municio, A. M.
    Pulido, J. C.
    Segurola, C. L.
    Romero, C. J.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 97 - 99
  • [9] Has the Model of End Stage Liver Disease (MELD) Improved Racial Disparities in Graft Survival for Liver Transplant Recipients?
    Jonassaint, Naudia L.
    Yenokyan, Gayane
    Boulware, L. Ebony
    GASTROENTEROLOGY, 2013, 144 (05) : S955 - S955
  • [10] Liver transplantation outcomes under the model for end-stage liver disease and pediatric end-stage liver disease
    Freeman, RB
    Harper, A
    Edwards, EB
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2005, 10 (02) : 90 - 94